Novartis
SWX:NOVN Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 123 Fair Values set on narratives written by author
WA
Consensus Narrative from 21 Analysts
Strong Pipeline With Scemblix And Kisqali Will Strengthen Future Prospects
Key Takeaways Strong product pipeline and strategic growth in priority brands signal potential for stable revenue and margin improvement, overcoming generic competition. International market expansion with effective protection strategies is expected to drive sustained revenue and earnings growth for Novartis.
View narrativeCHF 104.35
FV
7.4% undervalued intrinsic discount1.44%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
12 days ago author updated this narrative